Norway seeks to ease rules on biomaterials exchange
This article was originally published in Clinica
Executive Summary
At the start of December, the Norwegian health department will send a copy of its draft proposals regulating the transfer of biological material to and from foreign biobanks to healthcare institutions, industry associations and local authorities for evaluation. The aim is to ease these regulations in cases where international co-operation will not conflict with national interests or the protection of privacy.